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The provision of preventive cardiology services in the U.S.
will require a combination of the medical model of care and
of community preventive health programs. These ap-
proaches are complementary, synergistic, and each essential,
with a goal of “getting results” in the broadest possible
population. Organizations such as the American Heart
Association (AHA) and the National Heart, Lung, and
Blood Institute (NHLBI) have outlined algorithms for the
primary and secondary prevention of coronary heart disease
(CHD) (1–3), but it is a combination of medical-model and
community program approaches that will deliver preventive
care. In that the mortality from heart disease has dropped by
40% since 1970, the present approach is not without
positive results (4). The goal of this discussion is to describe
the types of clinical, community, and media programs that
have been effective in decreasing coronary risk in the general
public. Because an understanding of the principles of media
and communication are crucial to the success of any health
promotion program, the principles of effective media and
communication are briefly reviewed.
Physicians are generally well trained in defining the
presence of coronary risk factors and in the medical man-
agement of hyperlipidemia, hypertension, and diabetes.
Further training of cardiovascular (CV) specialists as leaders
in prevention (see Task Force Report #5) will assist in this
effort. Physicians are, however, far less capable of managing
and influencing lifestyle-related risk factors such as tobacco
use, diet, physical inactivity, and the consequences of
obesity. In addition, a brief office encounter does not lend
itself to the counseling and follow-up necessary to initiate a
change in unhealthy lifestyles. Broadening the physician
encounter to include non-physician personnel and commu-
nity resources will yield a greater impact in reducing
coronary risk. Furthermore, a high percentage of young
adults do not regularly visit physicians until the presence of
lifestyle-related conditions such as CHD or type II diabetes
are detected; thus, the role of public policy, school and
worksite programs, and mass-media should be emphasized.
Physicians, as role models and opinion setters, play a crucial
role in supporting the design and development of commu-
nity programs.
Numerous documents and position statements define
treatment goals for the prevention of CHD (2,5). Less clear
are the processes by which Americans might reach these
goals. It is only through a combination of community
programs, medical referral and treatment, and mass media
approaches to screening and therapy that the majority of
Americans will attain appropriate risk factor levels to sig-
nificantly reduce the incidence of CHD.
PROGRAMS OF GOVERNMENTAL AND
NON-GOVERNMENTAL ORGANIZATIONS
National Cholesterol Education Program. The National
Heart, Lung, and Blood Institute (NHLBI) of the National
Institutes of Health (NIH) launched the National Choles-
terol Education Program (NCEP) in November 1985 (5).
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The goal of the NCEP is to contribute to the reduction of
illness and death from CHD in the U.S. by reducing the
percentage of Americans with high blood cholesterol.
Through educational efforts directed at health professionals
and the public, the NCEP aims to raise awareness and
understanding about high blood cholesterol as a risk factor
for CHD and the benefits of lowering cholesterol levels as a
means of preventing CHD. The NCEP has organized a
number of panels, including the Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in
Adults (Adult Treatment Panel) that developed guidelines
for the identification and treatment of hyperlipidemia, most
recently updated in 2001 (3).
The NCEP also organized several other expert panels:
the Laboratory Standardization Panel that developed guide-
lines for standardizing laboratory measurements and report-
ing blood cholesterol tests; the Expert Panel on Population
Strategies for Blood Cholesterol Reduction (Population
Panel) that developed recommendations for reducing blood
cholesterol levels by adopting population-wide eating pat-
terns that are low in saturated fat and cholesterol; the Expert
Panel on Blood Cholesterol Levels in Children and Ado-
lescents that developed recommendations for heart-healthy
eating patterns for children and adolescents and recommen-
dations for detecting and treating high blood cholesterol in
children and adolescents from high-risk families; and the
Working Group on Lipoprotein Measurement that devel-
oped recommendations on lipoprotein measurement to
improve the determination of low-density lipoprotein-
cholesterol, high-density lipoprotein-cholesterol, and tri-
glycerides.
The efforts of the NCEP have been associated with
significant reductions in the prevalence of high blood
cholesterol in the U.S. and increases in the treatment of
hyperlipidemia (6). Since 1978, average total cholesterol
levels among U.S. adults have fallen from 213 mg/dl to 203
mg/dl and the prevalence of cholesterol of 240 mg/dl or
higher has declined from 26% to 19%.
Office on Smoking and Health and Agency for Health-
care Research and Quality. The lead government agency
for the control of tobacco is the Office on Smoking and
Health at the Centers for Disease Control and Prevention
(CDC) (www.cdc.gov/tobacco). The Office on Smoking
and Health provides a vast array of educational materials in
the form of printed materials and videos. It also conducts
surveys on tobacco use and expenditures for tobacco control.
The Agency for Healthcare Research and Quality recently
updated their Clinical Practice Guideline on Smoking
Cessation (http://www.surgeongeneral.gov/tobacco).
National High Blood Pressure Education Program. The
National High Blood Pressure Education Program (NHB-
PEP), established in 1972 (7), is a cooperative effort among
professional and voluntary health agencies, state health
departments, and many community groups. The NHBPEP
is coordinated by the NHLBI of the NIH (www.nhlbi.nih.
gov). The goal of the NHBPEP is to reduce death and
disability related to high blood pressure (BP) through
programs of professional, patient, and public education. The
NHBPEP also strives to achieve the heart disease and stroke
Healthy People 2010 objectives for the nation. Strategies to
achieve the program goals include developing and dissem-
inating stimulating educational materials and programs that
are grounded in a strong science base and developing
partnerships among the program participants. Throughout
its history, the NHBPEP has employed a comprehensive
strategy to mobilize, educate, and coordinate resources of
groups interested in hypertension prevention and control.
The NHBPEP comprises a network of federal agencies,
voluntary and professional organizations, state health de-
partments, and numerous community-based programs. At
the core of the program is the NHBPEP Coordinating
Committee, composed of representatives from 38 national
professional, public, and voluntary health organizations and
seven federal agencies.
The consensus document on hypertension, the “Report of
the Joint National Committee on Detection, Evaluation,
and Treatment of High Blood Pressure” (JNC), first pub-
lished in 1976, has had five subsequent updates (7). The
JNC reports serve as guidelines for clinicians and commu-
nity groups. The reports have been distributed to all state
health departments, nearly every primary care clinician, and
all hypertension control programs in the nation and have
been translated into foreign languages as well. Identification,
treatment, and control of high BP improved significantly
between the time that the NHBPEP was organized and the
early 1990s (8). More recently, however, control of high BP
has declined significantly in at least some venues (9).
Since their inception, the NHBPEP and the NCEP have
conducted aggressive mass-media campaigns. Using TV,
radio, print, and outdoor media, the campaigns have helped
keep the issues of high BP and high blood cholesterol on the
public agenda and may have contributed to the detection
and control of these conditions.
Federally-sponsored physical activity and physical fitness
programs. The President’s Council on Physical Fitness and
Sport has as its mission: “To coordinate and promote
opportunities in physical activity, fitness, and sports for all
Americans, as directed by Executive Order 12345, as
amended.” The major functions include the promotion of
community and school physical activity and fitness pro-
grams, dissemination of information, and raising of public
awareness about the importance of physical activity and
fitness. The leadership of Healthy People 2010 priority area
on physical activity and exercise developed a major Youth
Fitness Campaign with the Advertising Council. In addi-
tion, the President’s Council promotes the conduct of the
school-based President’s Challenge Physical Fitness Awards
Program, the President’s Fitness Awards Program, the
President’s Sports Award Program, the conduct of Healthy
American Fitness Leaders recognition program, and the
Silver Eagle Corp program for older Americans. The CDC
has proposed strategies to increase physical activity with its
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Task Force on Community Prevention Services (10) and with
its Healthy People 2010 Program (11).
Programs of non-governmental organizations. Voluntary
organizations play several important roles in the prevention
of heart disease. In addition to creating an organizational
focus, they sponsor research, provide education, and gener-
ate advocacy for the financing of both federally supported
research programs and service programs. While both the
ACC and the AHA include in their mission the prevention
and treatment of heart disease through education and
advocacy, with the ACC focusing its educational efforts on
practitioners of cardiovascular disease (CVD) and the issues
that affect them directly. The AHA (www.americanheart.
org) has a more broadly based constituency that includes the
lay public. In addition to the prevention and treatment of
heart disease, the AHA includes the prevention and treat-
ment of stroke in its mission. Organizations that are
primarily non-physicians, such as the American Association
of Cardiovascular and Pulmonary Rehabilitation, the Amer-
ican College of Sports Medicine and the Preventive Cardi-
ology Nurses Association, also play an important role. The
greatest likelihood of substantial impact may proceed from
the teamwork among the disciplines.
Pharmaceutical corporations and food corporations,
much the same as commercial news services, are oriented
toward generating a profit for shareholders, although many
of their products may have favorable effects on CV health.
Their prominent involvement in media-based advertising
programs tends to be influenced by opportunities to gener-
ate interest in and markets for their products rather than by
any role in overall preventive cardiology efforts. Nonethe-
less, these industries have been very supportive of many
preventive efforts when their interests are coincident with
the efforts of national and local organizations to change
knowledge, attitudes, beliefs, and behavior.
The American Legacy Foundation was formed as a result
of the master settlement agreement between the Attorneys
General of 46 states and five territories and the tobacco
industry. The American Legacy Foundation (www.
americanlegacy.org) is a national, independent, public
health foundation located in Washington, DC. Among
Legacy’s top priorities are the reduction of tobacco use by
young people and support of programs that help people—
whether young or old—to quit smoking. Legacy is also
interested in working to limit people’s exposure to smoke
from other people’s cigarettes. A major part of Legacy’s
work includes explaining how smoking or chewing tobacco
damages an individual’s health and how tobacco use costs
society. Legacy’s work to date includes a major tobacco
youth prevention and education effort known as the Truth
Campaign. Grassroots and promotional events, advertising,
and an interactive web site allow teenagers to get the facts
about tobacco use and tobacco marketing and get involved
in the effort to do something about it.
COMMUNITY PROGRAMS
Cardiovascular disease has strong environmental, cultural,
lifestyle, and behavioral components. Coordinated commu-
nity approaches that support the preventive efforts of the
health care sector may promote an environment and an
educated population that makes prevention possible (12).
Community programs provide an opportunity to address the
large population-attributable risk of mild elevations of
various risk factors, the interrelation of several health-
related behaviors, and the potential efficiency of large-scale
interventions not limited to the medical care system (13).
Major community trials. The prevention of CVD through
community interventions makes theoretical sense but has
been difficult to demonstrate (12). The community preven-
tion concept has been tested in at least six major trials,
which are summarized in Tables 1 and 2.
The North Karelia Project (1972 to 1997) served a mainly
rural population with low socioeconomic status, high un-
employment, and very high ischemic heart disease mortality
relative to other areas of Finland (14). Among its diverse
strategies, the project solicited community input, empha-
sized client risk-factor tracking and follow-up, employed a
professional nursing staff, and promoted the integration of
public health interventions with primary medical care (15).
The project was associated with significant reductions in
smoking, serum cholesterol, and BP, and an accelerated rate
of decline of CHD and cancer mortality. North Karelia
remains a world leader in community health promotion
(http://www.cvhpinstitute.org/).
The Stanford Three Community Project (1972 to 1975 in
northern California), which targeted smoking, high blood
cholesterol, and high BP, emphasized non-clinical settings
(home, worksite, community) as optimal for learning and
the maintenance of learning. Results show that although
mass-media campaigns are cost-effective in promoting
awareness and can change many health habits in the
short-term, the addition of personal interaction promotes
long-term change. Predicted CV risk decreased by 15% to
20% (16).
During the 1980s, the NHLBI funded three major
demonstration studies to evaluate the effectiveness of com-
prehensive, community-wide health education in reducing
the risk of CVD. The Stanford Five-City Project (17), the
Minnesota Heart Health Program (18), and the Pawtucket
Heart Health Program (19) had many features in common
(20). All used public health intervention models to facilitate
the adoption of health practices at community and individ-
ual levels that would have an impact on hypertension,
smoking, and high cholesterol. Each included multifactorial
campaigns of education and risk reduction, lasting from five
to eight years, and simultaneously addressed the prevention,
treatment, and control aspects of hypertension, smoking,
high dietary fat, obesity, and sedentary lifestyle. The three
projects aimed at primary prevention through direct educa-
tion of health professionals, education of the public through
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Table 1. Features and Outcomes of Six Major Community CVD Prevention Trials
Trial/Reference Years Location
Intervention
Community Population
Comparison
Community
Study
Design Unique Focus
Associated Outcomes Relative to
Comparison Populations
North Karelia (14) 1972–1997 Rural Finland North Karelia 180,000 in region Similar region
and Finland
Prospective
controlled
Indigenous impetus.
Community ownership.
Integration with health care.
Sustained focus on risk factors
among individuals.
Improved risk factors. Reduced
cardiovascular and cancer deaths.
Stanford 3-CP (16) 1972–1975 Northern
California
3 towns 12–15,000 per town 1 similar town Prospective
controlled
Mass media only vs. mass media
plus individual attention to
high-risk individuals.
Improved risk factor knowledge,
saturated fat intake, cigarette
consumption, plasma cholesterol
and blood pressure control, and
projected cardiovascular risk by
15% to 20%. Mass media more
cost-effective.
Stanford 5-CP (17) 1980–1986 Northern
California
2 cities About 75,000 per
city
3 similar cities Prospective
controlled
Mass media only. No
individualized interventions.
Sustained improvements in blood
pressure but not in physical
activity. No reductions in
cardiovascular morbidity or
mortality.
Minnesota (18) 1981–1988 Minnesota,
North and
South Dakota
3 cities, small,
large, metro
Small: 25–40,000
Medium: 75–80,000
Metro: 80–115,000
3 similar cities Prospective
controlled
Face-to-face communications,
public events, TV
Higher education exposure scores and
favorable risk factor changes. No
reductions in cardiovascular
morbidity or mortality.
Pawtucket (19) 1984–1991 Southern New
England
1 city 70,000 in city 1 nearby
similar city
Prospective
controlled
Community organization,
campaigns; screening,
counseling and referral.
Transient improvements in risk
factors and risk ratio for projected
cardiovascular disease rates. No
reductions in cardiovascular
morbidity or mortality.
Franklin, Maine
(26)
1974–Present Rural Maine Franklin
County
40,000 in county Adjacent,
similar
counties and
state
Retrospective
ecologic
observation
Integration of public health,
medical care and community
resources. Risk factor
counseling, tracking and
follow-up over time by 1-on-
1 nurse encounters.
Reduced: total, cardiovascular and
cancer mortality; cardiovascular and
“preventable” hospitalizations and
hospital charges; and smoking
rates. Dose-dependent impact of
nurse encounters on death rates.
CVD  cardiovascular disease.
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media and personal contact, and community organization to
foster institutional and environmental support. Theoretical
underpinnings included varying degrees of social learning
theory, social network diffusion theory, and social market-
ing. Each program had unique characteristics. Stanford
excluded individualized interventions and used mass media
to target behavior change. Minnesota emphasized face-to-
face communications, public events, and television. Paw-
tucket focused on community organization, campaigns and
screening, counseling, and referral activities. A number of
surveys and interviews were conducted to evaluate the effects
of the interventions.
Individually, the three projects produced modest but
significant improvements in knowledge and risk factors
within intervention communities compared with controls.
Stanford documented significantly greater reductions in
several risk factors, 15% lower composite risk scores, and
sustained improvements for BP (21) but not for physical
activity (22,23). Minnesota observed higher education ex-
posure scores and favorable changes in blood cholesterol,
physical activity, and smoking in the intervention commu-
nities. Pawtucket produced transient improvements in
smoking, BP, lipids, physical activity, and projected CV risk
(24). In all three, the greatest effects were seen among lower
socioeconomic groups.
None of the three was able to demonstrate significant
differences in CV morbidity and mortality compared with
the control communities over the time period studied. Both
intervention and control communities demonstrated im-
proved disease outcomes, obscuring any differences. Data
from the Stanford Five-Cities, Minnesota, and Pawtucket
programs have been pooled and analyzed jointly (20). Time
trends were estimated for cigarette smoking, BP, total
cholesterol, body mass index, and CHD mortality risk in
men and women age 25 to 64. The joint estimates of the
effects of interventions were in the expected direction in
nine of 12 gender-specific comparisons but were not statis-
tically significant. Smaller-than-expected net differences,
due to secular trend and less-than-expected impacts, ap-
peared to explain the few statistically significant effects in
these three U.S. prevention trials. Lessons learned from the
Stanford (http://scrdp.stanford.edu/), Minnesota (http://
www.epi.umn.edu/), and Pawtucket (http://www.
cvhpinstitute.org/) projects have contributed substantially to
subsequent community health concepts and models.
The Franklin Cardiovascular Health Program (1974 to the
present) has served 23 communities scattered over 1,800
square miles in rural Franklin County, Maine. The Franklin
Program’s major objective has been to reduce CVD through
a comprehensive community program that integrates public
health and health care, and it focuses public, individual, and
heath professional attention on the importance of long-term
risk-factor detection and control. The program has been
eclectic, drawing inspiration and ideas from contemporane-
ous national initiatives and demonstration projects (includ-
ing Stanford, Minnesota and Pawtucket) and empirical,
with ongoing quality improvement. Key strategies have
included screening; counseling; referral; follow-up; continu-
ity (including mailed follow-up reminders); physician in-
volvement (including reciprocal referrals between physicians
and the program); community activation; and community,
patient, and professional education. Over time, the pro-
gram’s focus has expanded from hypertension to cholesterol,
smoking, and physical inactivity; and strategies have been
Table 2. Intervention Strategies of Six Major Community CVD Prevention Trials
Strategies
North
Karelia
Stanford
3-Community
Stanford
5-Cities Minnesota Pawtucket
Franklin
Maine
Community organization      
Mass media     Print only 
Environmental modifications  0  0  
Community groups  0    
Schools      
Worksites  0    
Groceries and restaurants      
Medical settings  0    
Professional education  0    
Health agencies collaboration  0    
Train local personnel  0    
Lay volunteer emphasis  0 0 0  0
Self-management focus 0     
Group education      
Risk factor screening   0   
Individual counseling   0   
Referral for medical care  0 0   
Client risk factor tracking  0 0  0 
Active client follow-up  0 0  0 
Professional nursing staff  0 0 0 0 
Primary medical care integration  0 0 0 0 
CVD  cardiovascular disease. “” indicates characteristic present, but does not imply equivalent intensity of intervention
components.
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broadened to include environmental and policy initiatives,
integration of cardiac rehabilitation with primarily-
telephonic CV nurse care support, and guideline-based,
software-enhanced, nurse-mediated risk-factor modifica-
tion at work-sites and physician practices (25).
Franklin Program outcomes have been assessed by means
of retrospective ecologic observational analysis with external
comparisons. During the 20-year period from 1974 to 1994,
the Franklin Program encountered more than half of the
adult population on at least two occasions, broadly distrib-
uted by site, gender, and age, in all towns and most
worksites. The program documented substantial risk-factor
improvement (increased detection, medical treatment and
control of hypertension and high cholesterol and reduced
smoking) among participants with and without known
CVD. Compared with the state of Maine and two demo-
graphically similar, adjoining counties, the Franklin Pro-
gram was associated with significant dose- and time-
dependent reductions in CV mortality (26). In addition,
Franklin County’s average total death rate fell from fifth
highest among Maine’s 16 counties in the 1960s to the
absolute lowest during the following 25 years (1970 to
1994). Franklin County now compares very favorably with
Maine’s other counties with respect to excess deaths from
chronic diseases (27), life expectancy (28), CV hospitaliza-
tions and hospital charges, smoking rates (14%, compared
with an average of 25%) (27), self-perceived health status,
and preventable hospital stays among Medicare and Med-
icaid enrollees (nearly 40% lower) (29). The Franklin
Program spawned Maine’s first Healthy Community Coa-
lition, has evolved into the Western Maine Center for Heart
Health at Franklin Memorial Hospital, and continues to
serve as a model for communities in New England and
beyond (http://www.fchn.org/fmh/wmchh/wmhhhome.htm).
Other community intervention programs. Rural popula-
tions have been characterized as “late adopters” of preventive
health behaviors and, thus, may be both at greater risk for
preventable CV and other chronic diseases and an ideal
laboratory for testing community interventions (30). For
example, both the Bootheel Heart Health Project in rural
Missouri (31) and the Heart to Heart Project in South
Carolina (32) have demonstrated that community interven-
tions can improve diet, physical activity, and cholesterol
awareness and screening. In rural Sweden, systematic risk
factor screening and counseling done by family physicians
and family nurses within the larger framework of a com-
munity intervention program for the prevention of CVD
was associated with improved risk factors and a 19%
reduction in CVD risk (33).
Innovative community interventions have also focused on
non-rural, multi-ethnic, socioeconomically disadvantaged,
and worksite populations. The Healthy Heart Community
Prevention Project targeted low-socioeconomic-status urban
African American populations with innovative approaches
(including barbershops, beauty salons, churches, and sport-
ing events) for screening and education (34). Immigrant
populations pose unique language and cultural challenges
(35). Worksite programs (at Coors Brewing, Travelers
Insurance, Providence Health System, Pacific Railroad,
Dupont, and Superior Coffee and Foods, among others)
have improved behavioral risk factors (36,37) and reduced
direct and/or indirect health care costs (38).
Community programs for youth. Childhood behaviors
lead to adult habits and disease. The severity of asymptom-
atic atherosclerosis in young people is proportional to the
cumulative presence of traditional CV risk factors (39),
including diet, physical activity, and obesity (40). Distress-
ingly, American children, especially African-American,
Hispanic, and Native-American children, are becoming
heavier and fatter (25).
Community efforts to improve childhood health behav-
iors have focused on schools. Sponsored by the NIH, the
Child and Adolescent Trial for Cardiovascular Health
(CATCH) was a randomized, controlled field trial involving
students from ethnically diverse backgrounds in public
elementary schools in California, Louisiana, Minnesota,
and Texas. The third- through fifth-grade intervention,
which included school food service modifications, enhanced
physical education (PE), and classroom health curricula, was
able to modify the fat content of school lunches, increase
moderate-to-vigorous physical activity in PE, and improve
eating and physical activity behaviors in children during
three school years (41). Concurrent family involvement
enhanced knowledge and attitudes toward changes in health
habits (42). Tobacco experimentation, BP, body size, and
cholesterol levels were not affected (43). Some behavioral
changes initiated during the elementary school years per-
sisted to early adolescence (44). The CATCH study (http://
www.sdhealth.org/catch/catch.html) may be a feasible
model for multi-level health promotion programs to im-
prove eating and exercise behaviors in elementary schools in
the U.S. (45,46). The Planet Health intervention in middle
schools included an interdisciplinary curriculum that was
taught within existing math, science, language arts, social
studies, and PE classes. To improve energy balance, the
curriculum emphasized a healthy diet and reduced television
viewing time, replacing this inactive time with physical
activities chosen by students. Reductions in obesity preva-
lence were documented for girls, and these reductions were
directly related to reductions in time spent watching televi-
sion (47,48) (sgortmak@hsph.harvard.edu). Finally, drug
abuse prevention programs (such as Life Skills Training)
conducted during junior high school can produce meaning-
ful and durable reductions in tobacco, alcohol, and mari-
juana use among multicultural youth (49) (http://
www.lifeskillstraining.com). Achieving greater parental
involvement and understanding of adolescent developmen-
tal issues remain major challenges for school-based pro-
grams (50,51).
“Putting it together”—some keys to successful commu-
nity interventions. Why have some community programs
succeeded and others had difficulty demonstrating success?
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Of the major community interventions reviewed here, only
North Karelia and Franklin, Maine, were associated with
demonstrable improvements in CV health outcomes. These
interventions, unlike Stanford, Minnesota, and Pawtucket,
served primarily rural populations, employed professional
nurses, tracked individual clients’ risk factors for more than
two decades, and intentionally integrated community pro-
grams with primary health care.
Is success a function of the community? The program?
The environment? The times? Are rural areas different from
urban settings? Are rural communities inherently more
coherent and self-reliant? Are rural populations at higher
risk to begin with? Is the success of an early adopter rural
community more readily apparent because it may be more
isolated, more easily assessed, and then compared with more
typical, late-adopter surrounding communities? Have
prominent institutions foiled their own efforts to demon-
strate a difference in their intervention communities by
simultaneously being opinion leaders for the rest of the
region (often “control” communities) or country? Have
some community interventions intentionally devised non-
medical interventions and thus failed to build potentially
potent alliances between public health and health care? A
particularly important challenge will be to extend demon-
strated successes in rural communities to urban settings,
with programs adapted to cultural and linguistic variations.
A comprehensive community program integrates three mod-
els: clinical (health care professionals and institutions), public
health (interdependent systems connecting local, state, and
federal public health agencies), and health promotion (multi-
sector collaboration, including economic, education, health,
environment, employment, social services, government, and
multiple organizations). The comprehensive program uses
many channels of prevention (health care, community, work
sites, and schools) to prevent CVD in populations and
individuals. Key strategies, based on the experience and
understanding of the authors, are listed in Table 3.
Community programs may promote policy and environ-
mental changes that help prevent the development of risk
factors (primordial prevention) or make it easier for those
with risk factors (primary prevention) or disease (secondary
prevention) to modify their risks. Examples include the
identification and promotion of sites for safe indoor and
outdoor walking, and legislation to provide for smoke-free
school campuses, restaurants, and work places.
Community CVD prevention programs may focus on
factors both physiologic (e.g., weight, BP, lipids) and
behavioral (eating, activity, tobacco use, medication adher-
ence, psychosocial well-being, and early symptom recogni-
tion and response); they may provide opportunities for
screening, confirmation, referral, follow-up, monitoring,
education, and psychosocial support for behavior change;
they may serve individuals, families, groups, employers,
employees, hospitals, physicians, schools, community health
centers, food service providers (restaurants, groceries), and
government (state and local); and they may reach their
clients in public places and at special community meetings,
worksites, schools, and health care settings.
Momentum and sustained intervention may be crucial to
the success of community CV health programs. In years of
Table 3. Strategies That May Contribute to Successful Implementation of Community CVD Prevention Programs
Community Strategies Program Strategies
● Promote community ownership and openness to change.
● Mobilize, collaborate, network, and integrate with key
stakeholders and community resources.
● Employ multiple interventions through multiple channels: school,
worksite, health care, community.
● Develop and participate with coalitions: local, regional, state, and
national.
● Identify and nurture local health professional and community
champions.
● Nurture local medial advocacy.
● Know your community, and modify general principles to deal
with local realities, including cultural and resource issues. One
size does not fit all.
● Seek reliable, long-term funding, immune from legislative and
economic vagaries.
● Try to make financial and behavioral vectors point in the same
direction.
● Enable and reward health-promoting behaviors by individuals
and organizations.
● Seek win-win solutions:
● Promote concept that community hospital has service-area
responsibility for health promotion and disease prevention and
management, in addition to acute treatment.
● Promote development of functionally integrated medical care
networks.
● Have an enduring, consistent vision and mission.
● Be flexible in goals and objectives.
● Enjoy eclectic empiricism. (“What works works.”)
● Integrate three health models: medical, public health, and health
promotion.
● Strive to make enduring changes in systems, policies, and environment.
To have a lasting impact, education is necessary but insufficient.
● Continually improve quality: Design 3 Implement 3 Measure 3
Redesign.
● Obey Suttons’s Law: Go where the people are.
● Focus on continuous tracking, follow-up, and improvement of
modifiable risk factors among individuals and populations at risk for
preventable adverse outcomes.
● Adhere to national guidelines; synchronize with national movements and
topics (Healthy People 2010; new AHA guidelines and initiatives;
obesity, diabetes, tobacco use, physical inactivity). This gives credibility
and momentum.
● Facilitate supportive, strong 3-person teams: patient, physician,
professional nurse or other counselor.
● Produce best results by deploying teams of physicians and non-
physicians using multiple intervention modalities to deliver
individualized advice on multiple occasions.
● Promote integration of the community program with primary medical
care and community resources.
CVD  cardiovascular disease.
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Franklin Program growth, absolute death rates declined
faster in Franklin than in Maine and adjoining counties. In
years of program decline, absolute death rates in Franklin
County plateaued or rose slightly. In Pawtucket, the risk
ratio for projected CVD rates was 0.84 (p  0.02) during
peak intervention but dropped to 0.97 post intervention
(19). In California, initial benefits from comprehensive
community-wide tobacco control programs did not persist
(52) once funding was reduced, and associated reductions in
CV death rates have proved transitory (53). Sustaining
program momentum, particularly in the face of economic
decline, remains a major challenge.
CLINICAL INTERVENTIONS
Medical practice settings are presently underutilized as a
venue for providing prevention services to the public. This
reflects a health care system that focuses primarily on acute
care to the detriment of chronic care and prevention.
However, observational studies, randomized controlled tri-
als, and experience gained in the dissemination of models
into clinical practice suggest that CV risk-factor interven-
tions can be effectively implemented in medical practice
settings (54–56). Keys to success include systematic screen-
ing of individuals for coronary risk factors, utilization of
non-physician personnel to assist with behavioral change,
and the application of practice algorithms to guide pharma-
cologic therapy. Barriers to the implementation of preven-
tive cardiology care in medical settings include economic
barriers, a lack of motivation or interest on the part of
patients and a lack of skill or motivation on the part of
health care providers. An additional challenge to the effec-
tiveness of these systems is the gap that presently exists
between in-patient and out-patient services, highlighted by
the authors of the 11th Bethesda Conference Report in
1981 (57). The provision of funding through the Medicare
Program for prevention-related office visits and pharmaco-
logic therapy is currently being re-examined and may
expand the availability of preventive services for the Medi-
care population. The effects of health care economics and
reimbursement on the delivery of preventive cardiology
health care are addressed in Task Force #2 of this Bethesda
Conference. Success in CV risk reduction requires that
patients be educated and provided not only the appropriate
skills to help them adopt and maintain health behavior
changes but, in many cases, physiologic feedback as well.
Standard medical care often lacks the systems needed to
achieve these goals. For example, a lack of time often
prevents physicians from offering prevention services in
office practice settings. Yet even brief office-based educa-
tional interventions (3 to 8 min) provided by medical
professionals may produce beneficial outcomes in diet (54),
weight (54), blood lipids (54), smoking (58), alcohol con-
sumption (59), and physical activity (60,61). The success of
these interventions involves a systematic approach that
includes the training of physicians and other health care
providers by academic detailing, role-playing, and case-
study presentation, in addition to didactic presentation,
standardized patient education materials, the use of office
support staff to offer reminders and cues, and participation
in supporting educational interventions (62). Without all of
these elements, the implementation of educational interven-
tions that incorporate practice guidelines is generally unsuc-
cessful.
Although clinical practice guidelines offer the mandate
for practice based on randomized controlled trials and
expert opinion, they seldom offer a road map to ensure the
broad application of them (63). Systems with outcome
assessment and quality improvement that ensure the broad
application of the guidelines in clinical practice settings
need to be developed (64–66). Moreover, it is the thought-
ful systematic application of interventions that has proven to
be successful in improving patient outcomes in CV risk
reduction. Finally, one must determine who has the time
and skills to offer the services to help individuals during
their follow-up as they embark on lifestyle changes, receive
medical therapies, and monitor their symptoms: physicians,
nurses, and allied health professionals such as dieticians,
exercise physiologists, psychologists, and others may all play
a role.
Various clinic-based systems have been developed to
provide CV risk reduction services in both primary and
secondary prevention (Table 4) (67–71). Many of these
models relied on nurses and nurse practitioners to coordi-
nate the services of a multidisciplinary team, including
dietitians, pharmacists, social workers, exercise physiolo-
gists, and psychologists. The success of these models is
largely due to the availability of defined protocols for
management of medications, the development of compre-
hensive well-defined treatment plans, weekly team meet-
ings, individualized education of patients, and coordinated
care (e.g. pre-appointment reminders, use of home health
agencies, and so forth). Patients often present with several
medical and psychosocial problems. Many of these pro-
grams are associated with improved patient outcomes, but
little work has been conducted in evaluating their cost-
effectiveness.
In addition to clinic-based models, nursing case manage-
ment has proven to be effective in CV risk reduction in both
primary and secondary prevention (Table 4) (55,68,72–77).
Case management involves having a single individual, usu-
ally a nurse, coordinate both the determination of overall
cardiac risk and the delineation of a therapeutic plan based
on established guidelines to reduce cardiac risk. Case man-
agement has been applied to screen and educate large
populations (74) and to intervene in single risk factors such
as dyslipidemia (73), diabetes (72), or smoking (75,76)
and/or in multiple risk factors (55,77,78). Case manage-
ment systems have also been applied to older, sicker patients
with heart failure (70,79) and multiple CV or other co-
morbidities (80). The interventions have taken place in
differing health care settings, including academic medical
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Table 4. Primary/Secondary Medical Models for CVD Prevention
Reference Population and Study Design Intervention Components of Intervention Outcomes
Shaffer and Wexler, 1995 (67) ● Convenience sample
● High-risk dyslipidemic patients
comparison of lipid team
versus general internal
medicine
● n  120
● Mean age–61 yrs F/U 18
months.
Lipid intervention team led by
RN (Pharmacist, NP,
dietician, clinical
psychologist) (Lipid
management)
● Clinic visit by RN including health and
physical exam, review of lipid profile and
secondary causes. Referral to endocrinologist
as needed
● Dietary counseling by dietician (all pts)
● Screening by health psychologist for
behavioral barriers to lifestyles change
● Printed health education materials and
individualized treatment plan
● Follow up visits every 3 months (RN and
dietician)
● At 18 months, reduction in total cholesterol
(19% int. vs. 10% u.c. p  0.02) and LDL
cholesterol (26% int. vs. 8% u.c., p  0.01).
● No significant change in TGs or HDL
between groups
Aubert et al., 1998 (72) ● RCT
138 type 1 (n  17) and type 2
(n  121) patients
● Mean age–54 yrs F/U 12
months
Nurse case management
(patients recruited from 2
large primary care clinics)
(Diabetes management)
● Care provided by nurse case manager
● Treatment algorithms developed by
multidisciplinary team
● Baseline visit with RN (45 min) and 2 week
F/U (glucose mon., med adj. meal planning)
● Referral to 5 weeks, 12 diabetes education
program (dietician, exercise psychologist)
● Quarterly F/U visits (RN)
● Biweekly telephone contacts for review of
glucose logs and medications adjustment
● At 12 months, change in HbAlc - 1.7 (9.0
3 7.3) (int.) compared to 0.6 (8.9 3 8.3)
(uc) p  0.01
● Change in fasting glucose: 48.3 (194–146
mg/dl int.) vs. 14.5 (191–176 mg/dl u.c.)
(p  0.003)
● Improved perception of health status at 12
months in int. patients (p  0.02)
Taylor et al., 1990 (75) RCT
173 Post-MI males
● Mean age–54 years F/U 12
months
Nurse case management
(patients recruited from
large staff model HMO)
(smoking cessation)
● Behavioral counseling for smoking cessation
at bedside by RN (30 min)
● Health education pamphlet/audiotape
● Nicotine replacement therapy as needed
● Follow-up telephone contacts (10 min) at
48 h, 21 days, and monthly through 6
months
● At 12 months, biochemically documented
smoking cessation 71% (int.) vs. 45% (u.c.),
p  0.003
DeBusk et al., 1994 (55) RCT
585 Post-MI patients
● Mean age–57 yrs F/U 12
months
Nurse case
management/liaison
cardiologist (patients
recruited from large staff
model HMO) (Multiple
risk factor interventions)
● In-hospital baseline/education visit by RN
● Behavioral education/counseling for diet,
exercise and smoking primarily by telephone
(11 telephone contacts over 12 months)
● Protocol-driven medical algorithms for lipid
management
● Referral to other health disciplines as needed
(dietitian, psychologist)
● At 12 months, mean exercise capacity
(METS) 8.6 3 10.3 (int.) vs. 9.1 3 9.9
(u.c.), p  0.01 LDL cholesterol 107 mg/dl
(int.) vs. 132 mg/dl (u.c.), p  0.001
smoking rate 70% (int.) vs. 53% (u.c.), p 
0.03
Haskell et al., 1994 (78) RCT
300 patients with documented
CAD
● Mean age–57 yrs F/U 4 years
Clinic-based intervention team
(RN, MD, psychologist,
dietitian) and nurse case
management (Multiple risk
factor interventions)
● Baseline visit by nurse and dietitian
● Risk reduction goals including written health
educations materials
● Individual follow-up via phone/mail by
nurses re: patient progress
● Lipid-lowering medications provided under
protocol
● Clinical visits every 2–3 months with project
staff (5–7 visits/yr)
● Significant 4-year improvements in risk
factors LDL (22%) 2 HDL (12%) 1 TGs
(20%) 2 Exercise capacity (20%) 1 Diet
Fat (24%) 2 Diet cholesterol (40%) 2
Body weight (4%) 2
● Significant (47%) 2 in narrowing of
diseased coronary artery segments vs. u.c.
● Reduction in clinical cardiac events (25 int.
vs. 44 u.c., p  0.05) 623
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Table 4. Continued.
Reference Population and Study Design Intervention Components of Intervention Outcomes
Rich et al., 1995 (70) RCT
282 CHF patients
● Mean age–79 yrs F/U 3
months
Nurse-directed multi-
disciplinary team
(Heart failure)
In-hospital:
● Education using teaching booklet by RN
● Dietary assessment int. by dietitian
● Social service consultation re: discharge
planning
● Analysis of medications by geriatric
cardiologist
Posthospital:
● Individualized use of home health/telephone
contact by RN for education, compliance,
surveillance
● Survival without readmission at 90 days
91/142 (intervention) compared to 75/140
(controls), p  0.09.
● Heart failure readmissions 2 56% (54
intervention vs. 24 controls, p  0.04)
● Multiple readmissions (23% intervention vs.
9% controls, p  0.01)
● Improvement in quality of life (baseline 3
90 days) intervention group, p  0.001
Naylor et al., 1999 (80) RCT
363 elderly chronically ill (79%
cardiovascular)
● Mean age–75 years F/U 6
months
APNs (Elderly chronically ill
individuals)
● Hospital visits every 48 h by APN
● Discharge planning by APN-individualized
comprehensive home follow up protocol for
patient/caregiver
● Written discharge summaries provided to all
health care providers/patients/caregivers
● Home visits by APN at 48 h, 7–10 days, and
individualized per patient thereafter
● Weekly telephone contact with
patient/caregivers–6 months
● Readmission rate 37.1% (usual care) vs.
20.3 (intervention), p  0.001
● Multiple readmission rate 14.5% (usual
care) vs. 6.2 (intervention), p  0.01
● Total Medicare reimbursements significantly
reduced ($1.2 million (usual care) vs. $0.6
million (intervention) p  0.001)
● No significant difference in acute care visits,
functional status, depression or patient
satisfaction
Fonarow et al., 2001 (126) Comparison sample
Consecutive Post-MI patients
(n  558)
● Mean age–70 yrs F/U 12
months
Team of physicians and nurses
(Secondary prevention
treatments)
● Development & dissemination of focused
treatment algorithm for all secondary
prevention treatments
● Standardized admission orders (pre-printed)
● Patient education/counseling by cardiac
nurses re: risk factors/tests
● Patient education materials on risk of
atherosclerosis/benefits of compliance
● Comparison (1992–1933) prior to
implementation and two-year period after
implementation (1994–1995): Significant
improvements in aspirin, beta-blockers,
ACE inhibitors and statins pre vs. post int.
(p  0.01)
● Reduction in recurrent MI, hospitalization,
cardiac mortality and total mortality (p 
0.05)
ACE  angiotensin-converting enzyme; APN  advanced practice nurses; CAD  coronary artery disease; CHF  congestive heart failure; CVD  cardiovascular disease; F/U  follow-up; HDL  high-density lipoprotein; HMO 
health maintenance organization; LDL  low-density lipoprotein; MD  medical doctor; METS  metabolic equivalents; MI  myocardial infarction; RCT  randomized controlled trial; RN  registered nurse; TG  triglycerides.
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care centers, primary care clinics of large HMOs, and homes
(55,80). Many have relied on the telephone as the primary
mode of communication with patients (55,72,78). These
programs have used specially trained nurses and nurse
practitioners to provide multifactorial interventions in lieu
of a team of health care professionals. For moderate-to-
high-risk patients with diabetes, established CVD, and
heart failure, case management systems have proven respon-
sive to the basic needs of patients. Such programs enable an
access to broader resources and expertise and greater oppor-
tunities for close follow-up. They also foster closer adher-
ence to evidence-based guidelines and facilitate communi-
cation with clinical experts. Finally, they incorporate
databases to collect and organize data for individual patients
and populations (81). The majority of case management
programs have been shown to be effective in improving
overall patient care (55,68,72,75,78,80). Effectiveness is
measured by: 1) a greater achievement of goals such as BP,
smoking cessation, and hemoglobin A1c (HbA1c) levels; 2)
improvement in the quality of life; 3) an increase in
short-term compliance; and 4) reductions in medical re-
source utilization, including fewer emergency room visits
and hospitalizations. The cost-effectiveness of this type of
care, the appropriate length of intervention time, the ap-
propriate caseload, and the capability of such systems to
improve long-term compliance have not been studied ex-
tensively (81,82). Moreover, how these programs link to
other large population-based approaches and to standard
clinical care requires further study. Models combining case
management and the application of less intensive interven-
tions for low-risk populations are currently being tested
(83). To the contrary, the combination of the markedly
increased risk for future coronary events in patients with
established coronary disease (84) and the availability of
various effective pharmacologic agents for the prevention of
second coronary events (2) largely relegates the medical
management of patients with CHD to physicians and
nurses in their office practices. Newer models that rely on
nurses and physicians to bridge the gap between hospital-
ization and out-patient care such as the AHA’s “Get With
the Guidelines” program may also enable a larger number of
patients to be more effectively managed.
Cardiac rehabilitation programs are evolving from being
primarily a site for highly monitored exercise programs for
recently hospitalized cardiac patients to “secondary preven-
tion centers” that provide a collection of preventive services
for patients with established heart disease (85–88). These
services include screening and treatment of hyperlipidemia,
hypertension, diabetes mellitus, and obesity (86). Treatment
programs consist both of counseling related to nutritional
and psychological issues and the provision and adjustment
of pharmacologic therapy for risk factors such as hyperlip-
idemia and hypertension (86,88,89). Exercise conditioning
remains a central focus both for its preventive effects (90,91)
and for the prevention of work-related and age-related
disability (92). The case-management approach to cardiac
prevention in cardiac rehabilitation has been widely adopted
(55,78,93), with case managers focusing on individualized
programs to reach short- and long-term risk-factor goals
(78). A limitation of the delivery of secondary preventive
services at cardiac rehabilitation programs is that, at present,
only roughly 15% to 20% of patients attend cardiac reha-
bilitation after an acute coronary event, due in part to a
geographic maldistribution of available programs (85).
The success of the systems noted above depends on the
individualization of interventions and the availability of
more time that can be offered by a single health care
professional such as a registered nurse or exercise physiolo-
gist. Innovations in technology are certain to influence the
dissemination of these systems in the future. For example,
the use of computers and telephones to link patients and
health care professionals increases knowledge, medication
compliance, satisfaction with care, and quality of life, while
it reduces utilization of medical care resources (94). Elec-
tronic medication sensors such as BP monitors, blood
glucose meters, and interactive voice-recognition technol-
ogy will facilitate the gathering of data that are currently
difficult to retrieve. Real-time, online analysis of data, linked
to patient reminders will enable more highly individualized
management. Finally, technology will continue to simplify
some of the most time-consuming tasks of data manage-
ment and patient counseling that are faced by health care
professionals attempting to manage CV risk reduction.
Educational systems that incorporate the process of health
behavior change and provide individualized tailored mes-
sages, such as the “My Heart Watch” program offered by the
AHA, allow users to work at their own pace as they
continue to attempt difficult changes. These systems have
the potential to complement the office visit and promote
effective health behavior changes in large populations of
individuals at risk for CVD and its complications.
MEDIA AND COMMUNICATIONS
Whether a program message is delivered to a single indi-
vidual or to an entire community, effective communication
is necessary if behavior is to change. The role of media in
implementing health interventions includes media as edu-
cator, media as supporter, media as promoter, and media as
supplement (95). The goal of media targeted at the indi-
vidual level is to change awareness, knowledge, attitudes,
self-efficacy, skills, and behavior. Health-promotion orga-
nizations and health educators can reach defined target
audiences, tailor interventions to specific contexts, and
multiply their efforts by using existing organizational re-
sources. At the societal level, mass media can be used in an
attempt to affect normative behavior, laws and policies, and
physical and information environments.
Commercial news services. The commercial media are
powerful in their ability to expose vast numbers of people to
stories, messages, and information about health and to build
the public agenda for health-promoting policies. As noted
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by Finnegan (96), however, because their primary purpose is
not improvement of public health per se, the relationship of
health-oriented organizations and the media is dynamic and
not easily controlled.
Schooler et al. (97) have demonstrated that news can be
generated by an intervention program at the local level, and
under the right conditions, newspapers will cover health
promotion efforts. Finnegan et al. (96) documented that
national coverage of heart disease issues was highest in the
years 1983, 1984, and 1985, with a decline after that time to
basal levels.
Paid advertising. Paid advertising has the advantage of
being controllable by the program that sponsors it. The
major disadvantage relates to expense. However, Reger et al.
(98–100) have shown that, with a relatively inexpensive
campaign of paid advertising, they were able to shift
consumer demand from whole and 2% milk to 1% and skim
milk. Total milk sales also increased.
Health communication campaigns. Mass media can play
an important role in reducing CV risk. A creative way to
bring these media forces together is through a CVD health
communication campaign. Communication campaigns have
been described as a purposive set of communication activi-
ties aimed at a large audience within a defined period of
time (101).
Over the last 25 years, health communication campaigns
have played a prominent role in national efforts to reduce
heart disease, cancer, stroke, and accidents, the four leading
causes of death and disability in the U.S. (102–104). The
goal of most health communication campaigns has been to
bring about some change in the knowledge, attitudes, or
behavior of individuals clustered into a demographic or
sometimes psychographic target audience.
The effects of health communication campaigns can have
several dimensions. Effects can be short-term or long-term,
immediate or cumulative, planned or unplanned. Effects can
occur at the individual level, the group level, the organiza-
tional level, the societal level, or the cultural level (105). An
effect of a health communication campaign can be an
increase in cognitive complexity (106) or a gap in cognitive
complexity (107). A communication campaign may also
have the effect of setting a news agenda or a personal agenda
(108) that may create a knowledge gap between the higher
socioeconomic groups in a social system (who tend to
assimilate the information) and lower socioeconomic groups
(who tend not to assimilate the information) (109).
Communication researchers have differed on the signifi-
cance of the change brought about by communication
campaigns. Early reviews of health communication cam-
paigns (107,110–113) concluded that health communica-
tion campaigns did little to alter negative health practices.
More recently, researchers have cited the Stanford Three
Community Study, the Stanford Five City Project, and the
North Karelia project to point out that health communica-
tion campaigns can have positive effects, including changes
in the health status of the target audience (114). However,
rather than anticipating large behavior changes, many re-
searchers now believe that small but overt behavior changes
can be an outcome of communication campaigns (114).
In an exhaustive review of dozens of health communica-
tion campaigns conducted after 1980, Freimuth (115) iden-
tified the size of the effect generated by campaigns. Fre-
imuth distinguished six types of effects, in a hierarchy of
persuasion, that campaigns typically seek to bring about:
awareness, information seeking, knowledge gain, attitude
formation, behavioral intention, or behavior change. Fre-
imuth found larger effects in the earlier stages of the
hierarchy (i.e., awareness, information seeking, knowledge
gain) and more modest effects in the later stages (i.e.,
attitude change, behavior intentions, behavior change).
SOCIAL MARKETING PRINCIPLES. Social marketing is a
well-tested strategy that weaves theory and the lessons from
previous campaigns into a structured process of campaign
development. Social marketing uses the concepts of market
segmentation, consumer research, concept development,
communication, facilitation, incentives, and exchange the-
ory to maximize target-group response (116). According to
exchange theory, people exchange a resource (time, money,
behavior) for a benefit (a product or a positive attribute such
as health). Exchange theory is based on the idea that people
will make rational decisions in their own best interest (i.e.,
satisfy a need or want by obtaining the most benefit for the
least price). Social marketing seeks to facilitate that ex-
change by reducing the psychological, social, economic, and
practical distance between consumer and behavior.
Researchers have developed a variety of schema to depict
the social marketing process. One schema used by several
health communication campaigns is described in detail in
Making Health Communications Work published by the
Department of Health and Human Services (117). In this
schema, the social marketing process is segmented into six
distinct but sometimes overlapping stages.
1. Planning and strategy selection to identify a primary
audience, establish the goals for the campaign, analyze
existing information about a health issue, and quantify
the type or extent of change the campaign will seek to
achieve;
2. Selecting channels such as print, television, Web, or radio
and planning materials such as public service announce-
ments, brochures, video, interactive media, easy-to-read
material, and so forth;
3. Developing and pre-testing materials to ensure that they
are appropriate for and understood by the primary
audience;
4. Implementing the campaign, which involves “shepherding”
the campaign materials through the selected channels to
ensure that the messages reach the intended audiences;
5. Assessing effectiveness by measuring how well the cam-
paign is achieving the objectives established in stage one;
and
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6. Refining the campaign through feedback, which allows
campaign planners to adjust campaign strategy, re-
sources, and messages based on feedback received
through the campaign.
In the health arena, some practitioners and researchers
have criticized social marketing for promoting a single
solution to what is usually a complex problem (118). The
critics have argued that social marketing tends to reduce
serious health problems to individual risk factors and ig-
nores the importance of the social and economic environ-
ment as major determinants of health. The NCEP and the
media campaign that supports the NCEP demonstrate that
a well-conceived program can address both individual and
societal issues simultaneously.
Summary: media and communications effectiveness.
The most fundamental requirements for media and com-
munications effectiveness are that the messages’ content and
context be designed to flow through an individual’s social
network, be appropriate to the needs of the individual, and
follow empirically devised theories of human learning (119).
The strength of mass media is that they reach large to
very large audiences, but their weakness is that the audiences
reached are diverse and undifferentiated. Audience diversity
is a problem in that, to be effective, media messages should
be designed specifically for particular target audiences. The
weakness of targeted media (newsletters, booklets, self-help
kits, videos, and computerized information systems) is their
inability to reach large numbers of people.
Several investigators have shown that media is particu-
larly effective when used in conjunction with face-to-face
encounters (119). For example, Flay (120) reviewed the
literature on media and smoking cessation and found that
mass-media campaigns were reasonably successful in chang-
ing knowledge, attitudes, and in some instances, smoking
behavior. Mass-mediated smoking cessation clinics that
provided written materials were more successful than those
that did not, and mass-mediated clinics with social support
were more effective than either of the other methods.
Puska et al. (121,122) produced a nationally televised,
15-segment multi-risk television series over six months. The
show featured health experts and eight participants who
were attempting changes in behavior. The results were
positive and showed a graded effect between contact with
the program and behavior change.
The Stanford Three Community Study provides an
example of a long-term (three years), comprehensive media
program to achieve CV risk reduction (123). This study
compared the effects of mass media alone and mass media
supplemented with intensive face-to-face counseling. The
study showed that media alone can change behavior over the
short-term but that the addition of face-to-face interaction
enhances long-term change (16).
The value of face-to-face interaction to promote behavior
change is a recurring theme throughout diverse behavior
change literature. For example, in reviewing the process of
technological innovation, Tornatzky et al. (124) concluded
that face-to-face communication has a strong and positive
effect on the dissemination of innovations (page 159), while
“passive access [to information] does not lead to a high
volume of activity” (page 167). It is important to stimulate
demand for new technologies, and efforts to push new
technologies via development and demonstration are inef-
fective unless they are coupled with demand-creating activ-
ities (page 184). Gerlach and Hine (125) studied move-
ments of social change and concluded that mass media
primarily provide information and reinforcement of behav-
ior, whereas face-to-face recruitment is usually necessary for
individuals to undertake fundamental behavior change.
SUMMARY—GETTING
RESULTS: WHO, WHERE, AND HOW?
Despite the progress made in the past quarter century in
decreasing the incidence of CHD, it remains the major
cause of death for both men and women in the U.S. and in
other industrialized societies. A nationally coordinated pub-
lic policy effort that combines community programs, focus-
ing on healthy lifestyles and screening for risk factors, with
medical screening and treatment of patients at increased risk
would expand current efforts. The power of major health
promotion organizations and opinion leaders to foster
population changes in CVD risk should not be underesti-
mated.
In the absence of a nationally coordinated program,
increased integration of local efforts that encourage and
reward healthy behaviors, screen for CV risk factors, and
refer individuals to medical practices or hospital clinics for
treatment and surveillance will best advance the cause of
CVD prevention. Consolidation of resources, integrating
the support of government, health promotion organizations,
and private industry to use the media effectively to educate
and encourage lifestyle change will be a major challenge.
The role of government may need to be better defined, both
in terms of how it might coordinate and fund the overall
prevention effort on a national scale and how it might
expand its role in supporting healthy lifestyles at the local
level.
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Task Force #4—Adherence Issues and
Behavior Changes: Achieving a Long-Term Solution
Ira S. Ockene, MD, FACC, Co-Chair, Laura L. Hayman, PHD, RN, FAAN, Co-Chair,
Richard C. Pasternak, MD, FACC, Eleanor Schron, MS, RN, FAAN,
Jacqueline Dunbar-Jacob, PHD, RN, FAAN
INTRODUCTION: THE CHALLENGE OF ADHERENCE
Adherence (equivalent to compliance) to lifestyle and med-
ication recommendations for the prevention of cardiovascu-
lar disease (CVD) is a crucial element in the path from the
science of risk-factor modification to the actual reduction of
risk factors and consequent prevention of disease-related
events. Lack of adherence to therapeutic regimens has been
documented for decades, particularly for preventive inter-
ventions requiring changes in behavior such as smoking
cessation, change in eating patterns, physical activity, and
adherence to pharmacologic therapy (1,2). Pharmacologic
industry data (IMS Health; NDC Health Information
Services) document that by the end of one year, adherence
to preventive pharmacologic therapy has dropped to less
than 50% across several broad classes of drugs, including
hydroxy-methyl-glutaryl– coenzyme-A (HMG-CoA) re-
ductase inhibitors and angiotensin-converting enzyme in-
hibitors. Although non-adherence may consist of dropping
therapy altogether, there is also, a significant problem with
individuals who remain in treatment but fail to follow the
treatment regimen in sufficient quantity or appropriate
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